Related references
Note: Only part of the references are listed.Glucose-dependent insulinotropic peptide impairs insulin signaling via inducing adipocyte inflammation in glucose-dependent insulinotropic peptide receptor-overexpressing adipocytes
Yaohui Nie et al.
FASEB JOURNAL (2012)
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Katherine M. Flegal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Identifying Metabolically Healthy but Obese Individuals in Sedentary Postmenopausal Women
Virginie Messier et al.
OBESITY (2010)
Acylated and nonacylated ghrelin levels and their associations with insulin resistance in obese and normal weight children with metabolic syndrome
Lucia Pacifico et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Not all obese subjects of multiethnic origin are at similar risk for developing hypertension and type 2 diabetes
Virginia A. Genelhu et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
Are Natural Killer Cells Protecting the Metabolically Healthy Obese Patient?
Lydia A. Lynch et al.
OBESITY (2009)
The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering - Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004)
Rachel P. Wildman et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
High adiponectin concentrations are associated with the metabolically healthy obese phenotype
Carlos A. Aguilar-Salinas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance
Kirsten Vollmer et al.
DIABETES (2008)
Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women
Yiqing Song et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome
Rocco Barazzoni et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus
F. K. Knop et al.
DIABETOLOGIA (2007)
Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women
David H. St-Pierre et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Insulinogenic indices from insulin and C-peptide: Comparison of beta-cell function from OGTT and IVGTT
Andrea Tura et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2006)
The metabolically healthy but obese individual presents a favorable inflammation profile
AD Karelis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Elevated plasma glucose dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance
MJ Theodorakis et al.
DIABETES CARE (2004)
The evolution of β-cell dysfunction and insulin resistance in type 2 diabetes
RN Bergman et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients
MB Toft-Nielsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Reduced postprandial concentrations of intact biologically active gluccagon-like peptide 1 in type 2 diabetic patients
T Vilsboll et al.
DIABETES (2001)
Effect of GLP-1 on lipid metabolism in human adipocytes
ML Villanueva-Peñacarrillo et al.
HORMONE AND METABOLIC RESEARCH (2001)
Share Paper
